JGP Global Gestao de Recursos Ltda. trimmed its position in shares of Humana Inc (NYSE:HUM) by 50.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,119 shares of the insurance provider’s stock after selling 1,138 shares during the period. JGP Global Gestao de Recursos Ltda.’s holdings in Humana were worth $297,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Geode Capital Management LLC raised its position in Humana by 8.3% during the fourth quarter. Geode Capital Management LLC now owns 1,773,576 shares of the insurance provider’s stock valued at $507,198,000 after purchasing an additional 135,776 shares during the period. Thrivent Financial for Lutherans raised its position in Humana by 1.6% during the fourth quarter. Thrivent Financial for Lutherans now owns 6,837 shares of the insurance provider’s stock valued at $2,002,000 after purchasing an additional 106 shares during the period. Macquarie Group Ltd. raised its position in Humana by 459.4% during the fourth quarter. Macquarie Group Ltd. now owns 17,900 shares of the insurance provider’s stock valued at $5,128,000 after purchasing an additional 14,700 shares during the period. Actinver Wealth Management Inc. purchased a new stake in Humana during the fourth quarter valued at approximately $316,000. Finally, American Century Companies Inc. raised its position in Humana by 3.6% during the fourth quarter. American Century Companies Inc. now owns 55,085 shares of the insurance provider’s stock valued at $15,781,000 after purchasing an additional 1,932 shares during the period. 92.49% of the stock is owned by institutional investors and hedge funds.
A number of brokerages have issued reports on HUM. Citigroup downgraded BCE from a “buy” rating to a “neutral” rating in a research report on Thursday, May 2nd. Barclays set a $24.00 price objective on Tenet Healthcare and gave the company a “hold” rating in a research report on Wednesday, April 17th. Zacks Investment Research cut Hollysys Automation Technologies from a “hold” rating to a “sell” rating in a research note on Thursday, April 11th. UBS Group set a $36.00 target price on Halliburton and gave the company a “buy” rating in a research note on Tuesday, April 23rd. Finally, Oppenheimer cut their target price on Littelfuse from $215.00 to $210.00 and set an “outperform” rating on the stock in a research note on Thursday, May 2nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $336.42.
Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.24 by $0.81. Humana had a return on equity of 20.77% and a net margin of 2.99%. The company had revenue of $16.25 billion for the quarter, compared to analysts’ expectations of $15.88 billion. During the same quarter in the prior year, the firm earned $3.96 earnings per share. Humana’s revenue was up 13.9% compared to the same quarter last year. As a group, equities research analysts forecast that Humana Inc will post 17.48 EPS for the current year.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Read More: What does an equal weight rating mean?
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.